ArticleACS central science2026
Characterization and Applications of the Protein Corona Forming on the Naturally Occurring Nanoparticles, Low-Density Lipoproteins.
Article in ACS central science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Low-density lipoproteins (LDL) are naturally occurring, monodisperse nanoparticles composed of proteins and lipids with an average diameter of 18-25 nm. Their biological functions such as cholesterol trafficking and their role in various diseases have been extensively studied. However, their properties as nanoparticles are seldom discussed. Here, we show that when isolated from biofluids, analogous to any synthetic nanoparticle, LDL carry a distinctive protein corona. The corona can be partly removed or preserved depending on the approach used to isolate them. Importantly, we find that proteomic analysis of this corona enables proof-of-concept separation between healthy individuals and patients with melanoma, colon carcinoma, or liver cancer. This approach provided clearer separation than direct proteomic analysis of serum because the corona of the LDL particle is relatively depleted of the serum-abundant proteins, most of which are only minor components of the corona. We postulate that proteomic analysis of lipoproteins can reveal disease-associated changes and that a deep understanding of the corona of these particles will advance the overall field of nanoparticles in medicine.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.